Keyword: R&D

News

Merck Serono and Selvita in Oncology R&D Pact

28.10.2013 - Merck Serono, the biopharmaceuticals arm of Germany's Merck KGaA, has agreed an oncology research pact with Polish biotech company Selvita. The aim of the collaboration is to...

News

Some 650 European Jobs to Go as BASF Shifts Pigment Focus

24.10.2013 - As part of an ongoing drive to improve the competitive position of its pigment business, BASF plans to close at least one European production plant, at Paisley, Scotland, in 2015...

Plant Construction & Process Technology

Camelot’s Pharma Management Radar

24.10.2013 - End Of Patent Protection - The global pharmaceutical industry is steering toward the patent cliff: Some of the biggest blockbuster drugs in history - Lipitor, Plavix and Viagra -...

Plant Construction & Process Technology

Ashland’s Jeff Wolff on the Importance of Innovation

24.10.2013 - Transfomer - It was one of the biggest headlines of 2011 - Ashland Closes ISP Acquisition For $3.2 Billion.When the Kentucky-based specialty chemicals company wrapped up the deal...

News

BASF Lifts Crop Protection Sales Target for 2020

22.10.2013 - BASF has raised the 2020 sales target for its crop protection division by about a third. The German chemical group said it now expects to achieve revenues of €8 billion by 2020, up...

News

Ending Drug Trial Secrecy Is a Boon for R&D, Says EU Agency

22.10.2013 - Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug...

Chemistry & Life Sciences

Material Innovations Steer the Drive for more sustainable products

10.10.2013 - Corporations Get a Push from Plastics - For global material companies such as Styron, R&D departments have become increasingly important to enhance our customers' sustainability...

News

Astrazeneca CEO Gets Two Cheers after First Year in Job

01.10.2013 - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the...